Item 9 Labs

Item 9 Labs EBITDA per Share

The EBITDA per Share of Item 9 Labs (INLB) as of Nov 5, 2026 is -0.22 USD. In the previous year, EBITDA per Share was -0.05 USD — a change of 341.93% (lower).

EBITDA per Share

-0.22USD

YoY

341.93%

Last updated:

EBITDA per Share of Item 9 Labs is 2022 -0.22 USD. EBITDA per Share of Item 9 Labs was 2021 -0.05 USD. It decreases by 341.93% lower compared to the previous year.

The Item 9 Labs EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2015
-0.31 USD
Jan 1, 2016
-0.08 USD
Jan 1, 2017
0.00 USD
Jan 1, 2018
-0.01 USD
Jan 1, 2019
-0.07 USD
Jan 1, 2020
-0.08 USD
Jan 1, 2021
-0.05 USD
Jan 1, 2022
-0.22 USD
The Item 9 Labs EBITDA per Share history
YEAREBITDA per ShareYoY
-0.22USD+341.93%
-0.05USD-35.18%
-0.08USD+7.85%
-0.07USD+475.93%
-0.01USD-4,236.07%
0.00USD-100.36%
-0.08USD-73.40%
-0.31USD-11.84%
-0.35USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Item 9 Labs Stock analysis

What does Item 9 Labs do? Item 9 Labs Corp was founded in 2014 and is headquartered in Arizona, USA. As an innovative manufacturer of cannabis products, the company aims to revolutionize the industry and change the way the world views and uses cannabis. The business model of Item 9 Labs Corp focuses on developing and producing high-quality cannabis products. The company specializes in producing high-quality cannabinoid extracts for medical and recreational purposes. Item 9 Labs Corp's products are distributed by a network of retailers in Arizona and other states. Item 9 Labs Corp specializes in various sectors to meet the needs of customers in different areas. These sectors include the production of medical cannabis products, recreational cannabis products, and technological services for cannabis plant cultivation. Item 9 Labs Corp's medical cannabis products are tailored to the needs of patients affected by various health issues. These include products for pain relief, treating sleep disorders, anxiety and panic attacks, as well as treating nausea and other symptoms associated with different diseases. Item 9 Labs Corp's recreational products are designed for people who want to use cannabis for leisure activities. The company offers a wide range of products, ranging from traditional flowers to various concentrates and vapes. The company also has a division for technological services that focuses on optimal cannabis plant cultivation. Innovative and resource-saving methods are used to achieve optimal results. Item 9 Labs Corp aims to revolutionize the cannabis industry and find innovative ways to improve plant cultivation. To provide customers with the best products and services, Item 9 Labs Corp places great emphasis on quality and durability in the production of its product range. The company is known for using only the highest quality materials and conducting strict quality controls. The company has also built partnerships with retailers to ensure its products are available throughout Arizona. The company strives to develop new and innovative products that meet customer needs. This includes products that are tailored to the requirements of customers seeking a specific effect or experience, as well as products designed for specific symptom groups. Item 9 Labs Corp is a company dedicated to creating high-quality cannabis products. The company has extensive experience in the industry and has earned a reputation for innovation and quality. With a clear focus on customer satisfaction and product quality, Item 9 Labs Corp is on track to revolutionize the cannabis industry and become a leading player in the industry. Item 9 Labs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Item 9 Labs stock

EBITDA per Share of Item 9 Labs is -0.22 USD in 2022.

EBITDA per Share of Item 9 Labs changed from -0.05 USD to -0.22 USD, representing a 341.93% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Item 9 Labs since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Item 9 Labs

All Key Metrics — Item 9 Labs